Epidemiology

You have full text access to this OnlineOpen article

Kaposi's sarcoma risk among transplant recipients in the United States (1993–2003)†

  1. Sam M. Mbulaiteye‡,*,
  2. Eric A. Engels

Article first published online: 23 AUG 2006

DOI: 10.1002/ijc.22233

Issue

International Journal of Cancer

International Journal of Cancer

Volume 119, Issue 11, pages 2685–2691, 1 December 2006

Additional Information

How to Cite

Mbulaiteye, S. M. and Engels, E. A. (2006), Kaposi's sarcoma risk among transplant recipients in the United States (1993–2003). Int. J. Cancer, 119: 2685–2691. doi: 10.1002/ijc.22233

Author Information

  1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD

  1. ‡

    Fax: +1-301-402-0817

*6120 Executive Blvd, Executive Plaza South Rm. 7080, Rockville, MD 20852, USA

  1. †

    The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services.

Publication History

  1. Issue published online: 20 OCT 2006
  2. Article first published online: 23 AUG 2006
  3. Manuscript Accepted: 5 JUL 2006
  4. Manuscript Received: 15 MAR 2006

Funded by

  • Health Resources and Services Administration. Grant Number: 231-00-0115
  • Intramural Research Program of the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. Grant Numbers: N02-CP-31003, N01-CO-12400

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (167K)

References

  • 1
    Mendez JC, Paya CV. Kaposi's sarcoma and transplantation. Herpes 2000; 7: 18–23.
  • 2
    Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 2003; 17: 673–96,v.
  • 3
    IARC. Proceedings of the IARC working group on the evaluation of carcinogenic risks to humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon, France, 17–24 June 1997. IARC Monogr Eval Carcinog Risks Hum 1997; 70: 1–492.
  • 4
    Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, Angelico M, Leone P, et al. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect 2001; 43: 195–9.
  • 5
    Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997; 90: 2826–9.
  • 6
    Farge D, Lebbe C, Marjanovic Z, Tuppin P, Mouquet C, Peraldi MN, Lang P, Hiesse C, Antoine C, Legendre C, Bedrossian J, Gagnadoux MF, et al. Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation Qqd'qqspaceqqIle de France (GCIF). Transplantation 1999; 67: 1236–42.
  • 7
    Regamey N, Tamm M, Wernli M, Witschi A, Thiel G, Cathomas G, Erb P. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998; 339: 1358–63.
  • 8
    Luppi M, Barozzi P, Santagostino G, Trovato R, Schulz TF, Marasca R, Bottalico D, Bignardi L, Torelli G. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000; 96: 3279–81.
  • 9
    Barozzi P, Luppi M, Facchetti F, Mecucci C, Alu M, Sarid R, Rasini V, Ravazzini L, Rossi E, Festa S, Crescenzi B, Wolf DG, et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 2003; 9: 554–61.
  • 10
    Serraino D, Piselli P, Angeletti C, Minetti E, Pozzetto A, Civati G, Bellelli S, Farchi F, Citterio F, Rezza G, Franceschi S, Busnach G. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005; 92: 572–5.
  • 11
    Qunibi W, Al-Furayh O, Almeshari K, Lin SF, Sun R, Heston L, Ross D, Rigsby M, Miller G. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation 1998; 65: 583–5.
  • 12
    Dukers NH, Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. Aids 2003; 17: 1717–30.
  • 13
    Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, Jentsch U, Pacella-Norman R, Bourboulia D, Whitby D, Boshoff C, Weiss R. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999; 340: 1863–71.
  • 14
    Moosa MR. Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. Qjm 2005; 98: 205–14.
  • 15
    Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7: 147–56.
  • 16
    Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003; 43: 1260–68.
    Direct Link:
  • 17
    Hoshida Y, Tsukuma H, Yasunaga Y, Xu N, Fujita MQ, Satoh T, Ichikawa Y, Kurihara K, Imanishi M, Matsuno T, Aozasa K. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71: 517–20.
    Direct Link:
  • 18
    Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L, et al. Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer 1995; 60: 183–9.
    Direct Link:
  • 19
    Brunson ME, Balakrishnan K, Penn I. HLA and Kaposi's sarcoma in solid organ transplantation. Hum Immunol 1990; 29: 56–63.
  • 20
    Buell JF, Gross TG, Woodle ES Malignancy after transplantation. Transplantation 2005; 80: S254–S264.
  • 21
    Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317–23.
  • 22
    2004 OPTN/SRTR Annual Report 1994–2003. HHS/HRSA/HSB/DOT; UNOS; URREA. UNOS; URREA, 2004. Available at http://www.optn.org/
  • 23
    Boshoff C, Weiss RA. Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001; 356: 517–34.
  • 24
    Alzahrani AJ, El-Harith el HA, Milzer J, Obeid OE, Stuhrmann M, Al-Dayel A, Mohamed EA, Al-Egail S, Daoud M, Chowdhury A, Guella A, Aloraifi I, et al. Increased seroprevalence of human herpes virus-8 in renal transplant recipients in Saudi Arabia. Nephrol Dial Transplant 2005; 20: 2532–6.
  • 25
    Martin JN. Diagnosis and epidemiology of human herpesvirus 8 infection. Semin Hematol 2003; 40: 133–42.
  • 26
    Woodle ES, Hanaway M, Buell J, Gross T, First MR, Trofe J, Beebe T. Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc 2001; 33: 3660–1.
  • 27
    Biggar RJ, Horm J, Fraumeni JF,Jr, Greene MH, Goedert JJ. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973–81. J Natl Cancer Inst 1984; 73: 89–94.
  • 28
    Harwood AR, Osoba D, Hofstader SL, Goldstein MB, Cardella CJ, Holecek MJ, Kunynetz R, Giammarco RA. Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979; 67: 759–65.
  • 29
    Serraino D, Angeletti C, Carrieri MP, Longo B, Piche M, Piselli P, Arbustini E, Burra P, Citterio F, Colombo V, Fuzibet JG, Dal Bello B, et al. Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France. Transplantation 2005; 80: 1699–704.
  • 30
    Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94: 1204–10.
  • 31
    Farge D. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Eur J Med 1993; 2: 339–43.
  • 32
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol 1998; 152: 1433–43.
  • 33
    Moore PS. Transplanting cancer: donor-cell transmission of Kaposi sarcoma. Nat Med 2003; 9: 506–8.
  • 34
    Serraino D, Piselli P, Scuderi M, Gabbrielli F, Venettoni S, Grossi P, Nanni Costa A, Ippolito G. Screening for human herpesvirus 8 antibodies in Italian organ transplantation centers. Clin Infect Dis 2005; 40: 203–5.
  • 35
    Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. Aids 2003; 17: 1847–51.
View Full Article (HTML) Get PDF (167K)